USE OF EC-7072 AND SYNERGIC COMPOSITIONS THEREOF IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

USE OF EC-7072 AND SYNERGIC COMPOSITIONS THEREOF IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

The present invention is focused on a compound of Formula (I),or a pharmaceutically acceptable salt, co-crystal or solvate thereof, for use in treatment of chronic lymphocytic leukemia, as well as a composition comprising:(a) said compound of Formula (I), or a pharmaceutically acceptable salt, co-cr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: González Rodríguez, Segundo, Sordo Bahamonde, Christian, Pérez Escuredo, Jhudit, Lorenzo Herrero, Seila, Morís Varas, Francisco, Núñez González, Luz Elena, López Soto, Alejandro
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is focused on a compound of Formula (I),or a pharmaceutically acceptable salt, co-crystal or solvate thereof, for use in treatment of chronic lymphocytic leukemia, as well as a composition comprising:(a) said compound of Formula (I), or a pharmaceutically acceptable salt, co-crystal or solvate thereof; and(b) at least one chemotherapeutic agent selected from idelalisib or fludarabine, or a salt, co-crystal or solvate thereof.